At Q2 Solutions, we offer the processing of peripheral blood mononuclear cells (PBMCs) and bone marrow mononuclear cells (BMMCs) at our central laboratories across the world. All our processes are performed to globally harmonized standards ensuring consistently high yields, viability and recovery.
Global PBMC Network - 24-Hour Global Transit Time Map
Q2 Solutions supports our clients by providing integrated laboratory services to global and Asia-Pac regional biopharmaceutical companies who are developing compounds and/or conducting trials. Our...
Retroviral and lentiviral vectors are increasingly being used in the engineering of oncologic cell therapies; however, they may pose risk to human health in the event the viral vector becomes...
Genetic variation in neoplasia can take the form of single or multiple nucleotide variants, gene fusions, amplifications, and/or splice variations. This heterogeneity can pose a challenge in...